🇺🇸 FDA
Patent

US 6433023

Compositions having anti-leishmanial activity

expired A61KA61K31/095

Quick answer

US patent 6433023 (Compositions having anti-leishmanial activity) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/095